Squarepoint Ops LLC Biotechnology

Squarepoint Ops LLC

$80.7 Billion
Q1 2025

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
ALEC Alector, Inc.	$138M	$72,000 0.0% of portfolio	59,214	Q1 2025 Added 351.53%
RGNX Regenxbio Inc.	$376M	$72,000 0.0% of portfolio	10,204	Q1 2025 Reduced 72.59%
IMTX Immatics N.V.	$422M	$70,000 0.0% of portfolio	15,613	Q1 2025 New
SPRO Spero Therapeutics, Inc.	$103M	$66,000 0.0% of portfolio	92,939	Q1 2025 Added 68.82%
IPSC Century Therapeutics, Inc.	$32.4M	$63,000 0.0% of portfolio	132,929	Q1 2025 Reduced 19.37%
ABUS Arbutus Biopharma Corp	$471M	$60,000 0.0% of portfolio	17,356	Q1 2025 Reduced 90.25%
TNYA Tenaya Therapeutics, Inc.	$24.4M	$55,000 0.0% of portfolio	97,533	Q1 2025 Added 214.71%
IFRX Infla Rx N.V.	$38.5M	$54,000 0.0% of portfolio	53,513	Q1 2025 Added 360.17%
TARA Protara Therapeutics, Inc.	$34.1M	$52,000 0.0% of portfolio	12,232	Q1 2025 Reduced 41.06%
AVIR Atea Pharmaceuticals, Inc.	$303M	$47,000 0.0% of portfolio	15,756	Q1 2025 Reduced 68.95%
NKTX Nkarta, Inc.	$82.2M	$44,000 0.0% of portfolio	23,925	Q1 2025 New
ABCL Ab Cellera Biologics Inc.	$1.21B	$41,000 0.0% of portfolio	18,750	Q1 2025 Reduced 67.5%
ACIU Ac Immune Sa	$168M	$41,000 0.0% of portfolio	22,406	Q1 2025 Reduced 48.83%
MREO Mereo Biopharma Group PLC	$357M	$40,000 0.0% of portfolio	17,931	Q1 2025 Reduced 24.24%
SEER Seer, Inc.	$128M	$35,000 0.0% of portfolio	21,145	Q1 2025 Reduced 27.48%
BDTX Black Diamond Therapeutics, Inc.	$90.8M	$34,000 0.0% of portfolio	22,458	Q1 2025 Reduced 82.97%
BOLT Bolt Biotherapeutics, Inc.	$231M	$33,000 0.0% of portfolio	83,893	Q1 2025 Added 71.31%
CUE Cue Biopharma, Inc.	$25.8M	$31,000 0.0% of portfolio	34,778	Q1 2025 Added 76.72%
KOD Kodiak Sciences Inc.	$193M	$29,000 0.0% of portfolio	10,541	Q1 2025 New
HLVX Hille Vax, Inc.	$68.9M	$28,000 0.0% of portfolio	19,855	Q1 2025 New
PMVP Pmv Pharmaceuticals, Inc.	$54.7M	$23,000 0.0% of portfolio	21,896	Q1 2025 Reduced 70.01%
PASG Passage Bio, Inc.	$22.9M	$22,000 0.0% of portfolio	64,141	Q1 2025 Added 0.07%
OCGN Ocugen, Inc.	$210M	$21,000 0.0% of portfolio	29,919	Q1 2025 Added 68.98%
RLYB Rallybio Corp	$14.1M	$21,000 0.0% of portfolio	33,270	Q1 2025 Added 94.04%
NAUT Nautilus Biotechnology, Inc.	$99.7M	$20,000 0.0% of portfolio	23,899	Q1 2025 Reduced 9.21%
CVM Cel Sci Corp	$104M	$19,000 0.0% of portfolio	86,597	Q1 2025 New
ANVS Annovis Bio, Inc.	$21.7M	$18,000 0.0% of portfolio	12,574	Q1 2025 New
PYXS Pyxis Oncology, Inc.	$40M	$14,000 0.0% of portfolio	14,914	Q1 2025 New
MGNX Macrogenics Inc	$86M	$13,000 0.0% of portfolio	10,486	Q1 2025 New
ABOS Acumen Pharmaceuticals, Inc.	$49M	$12,000 0.0% of portfolio	11,189	Q1 2025 Reduced 5.3%
RPTX Repare Therapeutics Inc.	$59.6M	$11,000 0.0% of portfolio	11,890	Q1 2025 New
HOWL Werewolf Therapeutics, Inc.	$31M	$11,000 0.0% of portfolio	11,828	Q1 2025 New
ACET Adicet Bio, Inc.	$26M	$8,000 0.0% of portfolio	11,567	Q1 2025 Reduced 93.73%
SGMO Sangamo Therapeutics, Inc	$79.8M	$7,000 0.0% of portfolio	10,801	Q1 2025 Reduced 98.48%
LYRA Lyra Therapeutics, Inc.	$290M	$1,000 0.0% of portfolio	15,283	Q1 2025 New
SBTX Silverback Therapeutics, Inc.	$0	$0 0.0% of portfolio	76,824	Q1 2025 Added 210.06%

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.